<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01890031</url>
  </required_header>
  <id_info>
    <org_study_id>1R44HL097506-01</org_study_id>
    <nct_id>NCT01890031</nct_id>
  </id_info>
  <brief_title>Interactive Cholesterol Advisory Tool</brief_title>
  <acronym>ICAT</acronym>
  <official_title>The Interactive Cholesterol Advisory Tool</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to show that we can effectively deliver health information and
      education, online, via computer regarding cholesterol. This computer program is called the
      Interactive Cholesterol Advisory Tool (ICAT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be recruited and categorized based on screening labs into 1 of 2 groups:
      Low or moderate risk of developing cardiovascular disease within 10 years based on risk
      factors. The low risk group will be advised to take the blood test results furnished by the
      study to their primary care doctor to discuss managing cholesterol. The moderate risk group
      will see the study physician for 4 visits about high cholesterol. Both groups complete a
      total of 4 blood draws over 9 months. Both groups will be randomized at consent into 2
      groups: 1 who uses the Interactive Cholesterol Advisory Tool (ICAT) and 1 that does not use
      the ICAT. Because recruitment goals for the low risk group were met, a third group was
      created: low risk who both the study physician for 4 visits about high cholesterol and use
      the ICAT.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LDL-C in All ICAT Group Participants Versus Non-ICAT Group Participants</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Adhered to Medication Prescribed as Self Reported at 9 Months</measure>
    <time_frame>9 months</time_frame>
    <description>We will assess adherence (for those who are prescribed a statin in the moderate CVD risk group) by both indirect objective measures and subjective reports. The study design did not include prescription of a cholesterol-lowering medication as per randomization. Participants were prescribed a statin as standard of care based on the participants and physicians agreement. Low risk individuals have less need for medication compared to moderate risk based on the current science.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">131</enrollment>
  <condition>Low Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors</condition>
  <condition>Moderate Risk (10-20% Chance) of Developing Cardiovascular (Heart) Disease Within 10 Years Based on Risk Factors</condition>
  <arm_group>
    <arm_group_label>Low Risk, No ICAT</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Low risk, not randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low risk, ICAT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Low risk, randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low risk, ICAT, and study physician</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Low risk, assigned to use the Interactive Cholesterol Advisory Tool, and study physician visits.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate risk, no ICAT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Moderate risk, study physician visits, and not randomized to use the Interactive Cholesterol Advisory Tool</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate risk, ICAT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Moderate risk, study physician visits, and randomized to use the Interactive Cholesterol Advisory Tool</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interactive Cholesterol Advisory Tool</intervention_name>
    <description>using the virtual clinician computer program for cholesterol information and education.</description>
    <arm_group_label>Low risk, ICAT</arm_group_label>
    <arm_group_label>Low risk, ICAT, and study physician</arm_group_label>
    <arm_group_label>Moderate risk, ICAT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Study physician visits</intervention_name>
    <description>In-person individual visits with a study physician to give information on cholesterol</description>
    <arm_group_label>Low risk, ICAT, and study physician</arm_group_label>
    <arm_group_label>Moderate risk, no ICAT</arm_group_label>
    <arm_group_label>Moderate risk, ICAT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fluency in English,

          -  Willing to come in for 1-5 visits,

          -  Low and moderate CVD risk.

          -  Having access to a computer with internet connection

        Exclusion Criteria:

          -  CVD diagnosis or CVD equivalent,

          -  Psychosis, terminal illness,

          -  Pregnancy,

          -  Current statin use if assigned to the low risk group

          -  Liver disease,

          -  Peripheral Vascular Disease,

          -  Diabetes Mellitus,

          -  Abdominal Aortic Aneurism,

          -  Cerebral Vascular Disease

          -  Triglyceride level above 500 mg/dl

          -  Uncorrected hypothyroidism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Block, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2012</study_first_submitted>
  <study_first_submitted_qc>June 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2013</study_first_posted>
  <results_first_submitted>July 1, 2015</results_first_submitted>
  <results_first_submitted_qc>August 5, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 4, 2015</results_first_posted>
  <last_update_submitted>August 5, 2015</last_update_submitted>
  <last_update_submitted_qc>August 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Robert Block</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>cardiovascular disease</keyword>
  <keyword>cholesterol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Low Risk, No ICAT</title>
          <description>Low risk, not randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits</description>
        </group>
        <group group_id="P2">
          <title>Low Risk, ICAT</title>
          <description>Low risk, randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits
Interactive Cholesterol Advisory Tool: using the virtual clinician computer program for cholesterol information and education.</description>
        </group>
        <group group_id="P3">
          <title>Moderate Risk, no ICAT</title>
          <description>Moderate risk, study physician visits, and not randomized to use the Interactive Cholesterol Advisory Tool
Study physician visits: In-person individual visits with a study physician to give information on cholesterol</description>
        </group>
        <group group_id="P4">
          <title>Moderate Risk, ICAT</title>
          <description>Moderate risk, study physician visits, and randomized to use the Interactive Cholesterol Advisory Tool
Interactive Cholesterol Advisory Tool: using the virtual clinician computer program for cholesterol information and education.
Study physician visits: In-person individual visits with a study physician to give information on cholesterol</description>
        </group>
        <group group_id="P5">
          <title>Low Risk, ICAT, and Study Physician</title>
          <description>Low risk, assigned to use the Interactive Cholesterol Advisory Tool, and study physician visits</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="11"/>
                <participants group_id="P5" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="11"/>
                <participants group_id="P5" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Low Risk, No ICAT</title>
          <description>Low risk, not randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits</description>
        </group>
        <group group_id="B2">
          <title>Low Risk, ICAT</title>
          <description>Low risk, randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits
Interactive Cholesterol Advisory Tool: using the virtual clinician computer program for cholesterol information and education.</description>
        </group>
        <group group_id="B3">
          <title>Moderate Risk, no ICAT</title>
          <description>Moderate risk, study physician visits, and not randomized to use the Interactive Cholesterol Advisory Tool
Study physician visits: In-person individual visits with a study physician to give information on cholesterol</description>
        </group>
        <group group_id="B4">
          <title>Moderate Risk, ICAT</title>
          <description>Moderate risk, study physician visits, and randomized to use the Interactive Cholesterol Advisory Tool
Interactive Cholesterol Advisory Tool: using the virtual clinician computer program for cholesterol information and education.
Study physician visits: In-person individual visits with a study physician to give information on cholesterol</description>
        </group>
        <group group_id="B5">
          <title>Low Risk, ICAT, and Study Physician</title>
          <description>Low risk, assigned to use the Interactive Cholesterol Advisory Tool, and study physician visits</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="12"/>
            <count group_id="B4" value="11"/>
            <count group_id="B5" value="8"/>
            <count group_id="B6" value="131"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.5" spread="11.9"/>
                    <measurement group_id="B2" value="46.6" spread="13.5"/>
                    <measurement group_id="B3" value="53.3" spread="9.7"/>
                    <measurement group_id="B4" value="57.7" spread="8.8"/>
                    <measurement group_id="B5" value="51.4" spread="13.0"/>
                    <measurement group_id="B6" value="49.0" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="8"/>
                    <measurement group_id="B6" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>LDL Cholesterol</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125.5" spread="31.4"/>
                    <measurement group_id="B2" value="123.3" spread="32.5"/>
                    <measurement group_id="B3" value="130.4" spread="37.8"/>
                    <measurement group_id="B4" value="121.2" spread="41.7"/>
                    <measurement group_id="B5" value="129.9" spread="38.2"/>
                    <measurement group_id="B6" value="125.7" spread="33.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>LDL-C in All ICAT Group Participants Versus Non-ICAT Group Participants</title>
        <time_frame>9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Risk, No ICAT</title>
            <description>Low risk, not randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits</description>
          </group>
          <group group_id="O2">
            <title>Low Risk, ICAT</title>
            <description>Low risk, randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits
Interactive Cholesterol Advisory Tool: using the virtual clinician computer program for cholesterol information and education.</description>
          </group>
          <group group_id="O3">
            <title>Moderate Risk, no ICAT</title>
            <description>Moderate risk, study physician visits, and not randomized to use the Interactive Cholesterol Advisory Tool
Study physician visits: In-person individual visits with a study physician to give information on cholesterol</description>
          </group>
          <group group_id="O4">
            <title>Moderate Risk, ICAT</title>
            <description>Moderate risk, study physician visits, and randomized to use the Interactive Cholesterol Advisory Tool
Interactive Cholesterol Advisory Tool: using the virtual clinician computer program for cholesterol information and education.
Study physician visits: In-person individual visits with a study physician to give information on cholesterol</description>
          </group>
          <group group_id="O5">
            <title>Low Risk, ICAT, and Study Physician</title>
            <description>Low risk, assigned to use the Interactive Cholesterol Advisory Tool, and study physician visits</description>
          </group>
        </group_list>
        <measure>
          <title>LDL-C in All ICAT Group Participants Versus Non-ICAT Group Participants</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126.2" spread="32.3"/>
                    <measurement group_id="O2" value="126.0" spread="28.8"/>
                    <measurement group_id="O3" value="103.2" spread="35.1"/>
                    <measurement group_id="O4" value="107.7" spread="32.3"/>
                    <measurement group_id="O5" value="107.0" spread="45.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Adhered to Medication Prescribed as Self Reported at 9 Months</title>
        <description>We will assess adherence (for those who are prescribed a statin in the moderate CVD risk group) by both indirect objective measures and subjective reports. The study design did not include prescription of a cholesterol-lowering medication as per randomization. Participants were prescribed a statin as standard of care based on the participants and physicians agreement. Low risk individuals have less need for medication compared to moderate risk based on the current science.</description>
        <time_frame>9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Risk, No ICAT</title>
            <description>Low risk, not randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits</description>
          </group>
          <group group_id="O2">
            <title>Low Risk, ICAT</title>
            <description>Low risk, randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits
Interactive Cholesterol Advisory Tool: using the virtual clinician computer program for cholesterol information and education.</description>
          </group>
          <group group_id="O3">
            <title>Moderate Risk, no ICAT</title>
            <description>Moderate risk, study physician visits, and not randomized to use the Interactive Cholesterol Advisory Tool
Study physician visits: In-person individual visits with a study physician to give information on cholesterol</description>
          </group>
          <group group_id="O4">
            <title>Moderate Risk, ICAT</title>
            <description>Moderate risk, study physician visits, and randomized to use the Interactive Cholesterol Advisory Tool
Interactive Cholesterol Advisory Tool: using the virtual clinician computer program for cholesterol information and education.
Study physician visits: In-person individual visits with a study physician to give information on cholesterol</description>
          </group>
          <group group_id="O5">
            <title>Low Risk, ICAT, and Study Physician</title>
            <description>Low risk, assigned to use the Interactive Cholesterol Advisory Tool, and study physician visits</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Adhered to Medication Prescribed as Self Reported at 9 Months</title>
          <description>We will assess adherence (for those who are prescribed a statin in the moderate CVD risk group) by both indirect objective measures and subjective reports. The study design did not include prescription of a cholesterol-lowering medication as per randomization. Participants were prescribed a statin as standard of care based on the participants and physicians agreement. Low risk individuals have less need for medication compared to moderate risk based on the current science.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data were collected at over 9 months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Low Risk, No ICAT</title>
          <description>Low risk, not randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits</description>
        </group>
        <group group_id="E2">
          <title>Low Risk, ICAT</title>
          <description>Low risk, randomized to use the Interactive Cholesterol Advisory Tool, no study physician visits
Interactive Cholesterol Advisory Tool: using the virtual clinician computer program for cholesterol information and education.</description>
        </group>
        <group group_id="E3">
          <title>Moderate Risk, no ICAT</title>
          <description>Moderate risk, study physician visits, and not randomized to use the Interactive Cholesterol Advisory Tool
Study physician visits: In-person individual visits with a study physician to give information on cholesterol</description>
        </group>
        <group group_id="E4">
          <title>Moderate Risk, ICAT</title>
          <description>Moderate risk, study physician visits, and randomized to use the Interactive Cholesterol Advisory Tool
Interactive Cholesterol Advisory Tool: using the virtual clinician computer program for cholesterol information and education.
Study physician visits: In-person individual visits with a study physician to give information on cholesterol</description>
        </group>
        <group group_id="E5">
          <title>Low Risk, ICAT, and Study Physician</title>
          <description>Low risk, assigned to use the Interactive Cholesterol Advisory Tool, and study physician visits</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Robert Block, MD, MPH; Clinical Trial Director</name_or_title>
      <organization>University of Rochester</organization>
      <phone>585-275-3356</phone>
      <email>robert_block@urmc.rochester.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

